Telomere length and type 2 diabetes in males, a premature aging syndrome

Aging Male

Volumn 15, Issue 1, 2012, Pages 54-58

  Murillo Ortiz, Blanca ^a   Albarrán Tamayo, Froylán ^b   Arenas Aranda, Diego ^c   Benítez Bribiesca, Luis ^a   Malacara Hernandez J M ^b   Martínez Garza, Sandra ^b   Hernández González, Martha ^a   Solorio, Sergio ^a   Garay Sevilla, M E ^b   Mora Villalpando, Carmen ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF GUANAJUATO   (Mexico)

^c HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

Oxidative stress; Telomere shortening; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGING; ARTICLE; CONTROLLED STUDY; HUMAN; INFLAMMATION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

AGING, PREMATURE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; HUMANS; INTERLEUKIN-6; LIPID PEROXIDATION; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SYNDROME; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856887460     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2011.593658     Document Type: Article

References (32)

1. Zakian VA. Structure, function, and replication of Saccharomyces cerevisiae telomeres. Annu Rev Genet 1996;30:141-172. (Pubitemid 27014466)
2. Greider CW. Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Genet Dev 1994;4:203-211. (Pubitemid 24114851)
3. Das B, Saini D, Seshadri M. Telomere length in human adults and high level natural background radiation. Plos One 2009;4:8440.
4. Zee RY, Castonguay AJ, Barton NS, Germer S, Martin M. Mean leukocyte telomere length shortening and type 2 diabetes mellitus: a casecontrol study. Transl Res 2010;155:166-169.
5. Shay JW, Wright WE. Telomeres and telomerase in normal and cancer stem cells. FEBS Lett 2010;584:3819-3825.
6. Flores I, Blasco MA. The role of telomeres and telomerase in stem cell aging. FEBS Lett 2010;584:3826-3830.
7. Boehm BO, Möller P, Högel J. Lymphocytes of type 2 diabetic women carry a high load of stable chromosomal aberrations. Diabetes 2008;57:2950-2957.
8. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care 2006;29:283-289. (Pubitemid 44106505)
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
10. Son BK, Akishita M, Iijima K, Kozaki K, Maemura K, Eto M et al. Adiponectin antagonizes stimulatory effect of tumor necrosis factor- alpha on vascular smooth muscle cell calcification: regulation of growth arrest-specific gene 6-mediated survival pathway by adenosine 5?-monophosphate-activated protein kinase. Endocrinology 2008;149:1646-1653. (Pubitemid 351468314)
11. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. j Clin Invest 2005;115:1111-1119. (Pubitemid 40629025)
12. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002;30:e47.
13. Greider CW, Blackburn EH. Telomeres, telomerase and cancer. Sci Am 1996;274:92-97.
14. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y et al. Estrogen activates telomerase. Cancer Res 1999;59:5917-5921. (Pubitemid 30004951)
15. Meyne J, Ratliff RL, Moyzis RK. Conservation of the human telomere sequence (TTAGGG)n among vertebrates. Proc Natl Acad Sci usa 1989;86:7049-7053. (Pubitemid 19240864)
16. Adaikalakoteswari A, Balasubramanyam M, Mohan V. Telomere shortening occurs in Asian Indian Type 2 diabetic patients. Diabet Med 2005;22:1151-1156. (Pubitemid 41224172)
17. Solorio S, Murillo-Ortíz B, Hernádez-González M, Guillén-Contreras J, Arenas-Aranda D, Solorzano-Zepeda FJ et al. Association Between Telomere Length and c-Reactive Protein and the Development of Coronary Collateral Circulation in Patients With Coronary Artery Disease. Angiology 2011;DOI.10.1177&0003319710398007.
18. Uziel O, Singer JA, Danicek V, Sahar G, Berkov E, Luchansky M et al. Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control. Exp Gerontol 2007;42:971-978. (Pubitemid 47432738)
19. Aviv A, Valdes A, Gardner JP, Swaminathan R, Kimura M, Spector TD. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. j Clin Endocrinol Metab 2006;91:635-640. (Pubitemid 43236936)
20. Demissie S, Levy D, Benjamin EJ, Cupples LA, Gardner JP, Herbert A et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell 2006;5:325-330. (Pubitemid 44103248)
21. Iqbal N. The burden of type 2 diabetes: strategies to prevent or delay onset. Vasc Health Risk Manag 2007;3:511-520. (Pubitemid 47542612)
22. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-823. (Pubitemid 38620857)
23. Oikawa S, Kawanishi S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 1991;453:365-368.
24. Savage DB, Petersen KF, Shulman GI. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 2005;45:828-833. (Pubitemid 40628921)
25. Cawthon RM, Smith KR, OBrien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003;361:393-395. (Pubitemid 36164975)
26. Bischoff C, Petersen HC, Graakjaer J, Andersen-Ranberg K, Vaupel JW, Bohr VA et al. No association between telomere length and survival among the elderly and oldest old. Epidemiology 2006;17:190-194.
27. Gardner JP, Li S, Srinivasan SR, Chen W, Kimura M, Lu X et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation 2005;111:2171-2177. (Pubitemid 40632431)
28. Tentolouris N, Nzietchueng R, Cattan V, Lacolley P. White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria. Diabetes Care 2007;30:2909-2915. (Pubitemid 350089752)
29. Benetos A, Okuda K, Lajemi M, Kimura M, Thomas F, Skurnick J et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001;37:381-385. (Pubitemid 32198997)
30. Adaikalakoteswari A, Balasubramanyam M, Ravikumar R, Deepa R, Mohan V. Association of telomere shortening with impaired glucose tolerance and diabetic macroangiopathy. Atherosclerosis 2007;195: 83-89. (Pubitemid 47569984)
31. Maeda T, Oyama JI, Higuchi Y, Koyanagi M, Sasaki M, Arima T, Mimori K, Makino N. The correlation between clinical laboratory data and telomeric status of male patients with metabolic disorders and no clinical history of vascular events. Aging Male 2010; 14:21-26.
32. Al-Atlas OS, Al-Daghri NM, Alokail MS, Alfadda A. Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin. Eur J Endocrinol 2010; 163: 601-607.